# Avalon Healthcare Solutions

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avalon-healthcare-solutions

- Industry: Healthcare IT
- Headquarters: Tampa, US
- Website: www.avalonhcs.com
- Latest round: Series C (Dec 30, 2016)
- Investors on record: 4

## About

Avalon Healthcare Solutions, based in the US, specializes in delivering lab-driven insights through a digital platform, enhancing healthcare delivery with real-time lab data for improved clinical outcomes.Founded in 2013, Avalon Healthcare Solutions provides actionable insights through its innovative platform. The company is headquartered in Tampa, US. Bill Kerr serves as both the CEO and Founder. Avalon has secured a total of USD 16.5 mn in funding over several rounds, with the latest being a SERIES D round in July 2018 from HSBC Bank. To date, Avalon has completed a total of 4 deals, indicating its active engagement in the healthcare solutions sector.Avalon Healthcare Solutions specializes in providing actionable lab-driven insights through its innovative digital platform. The company's core offerings include solutions for lab insights, genetic testing management, routine test management, lab values management, and specialty pharmacy solutions. These products enhance the accuracy and efficiency of healthcare delivery by leveraging real-time lab data, ultimately improving clinical outcomes for individuals and populations. Avalon serves a diverse client base, including health plans and lab providers across the United States and select international markets, focusing on improving care delivery and reducing costs.Avalon Healthcare Solutions generates revenue through a combination of subscription-based services and partnerships with health plans and lab providers. The structure typically involves B2B agreements where clients subscribe to Avalon’s suite of lab insights solutions, gaining access to real-time data and analytics that enhance care management. Although specific pricing plans are not disclosed, the company’s flagship offerings, such as AvalonSelect and its genetic testing management solutions, are integral to its revenue model, fostering long-term client relationships.Looking ahead, Avalon Healthcare Solutions aims to expand its product offerings and market presence. Following the recent SERIES D funding round in July 2018, which raised USD 16.5 mn, Avalon plans to invest in the development of new products designed to enhance its digital platform. The company is targeting expansion into additional international markets by 2023, aiming to leverage its lab-driven insights to improve healthcare outcomes globally. In November 2025, WindRose Health Investors agreed to acquire a majority stake in Avalon Healthcare Solutions from HSBC Bank, Mosaic Health Solutions, Echo Health Ventures, BlueCross BlueShield of South Carolina, Inc., and Francisco Partners, as part of recapitalization. Francisco Partners re-invested in the company. The deal was completed in December 2025. The acquisition enables Avalon Healthcare Solutions to accelerate growth, expand diagnostic intelligence capabilities, and enhance its technology platform for health plan clients.

## Funding rounds

- Series C, Dec 30, 2016 — Francisco Partners, BlueCross BlueShield of South Carolina, Inc., Echo Health Ventures, Mosaic Health Solutions
- Series B, Jan 6, 2016 — Francisco Partners
- Seed, Jun 1, 2013 — Francisco Partners

## Investors

- Francisco Partners (https://capitalatlas.ai/funds/francisco-partners) — Seed, Series B, Series C
- BlueCross BlueShield of South Carolina, Inc. — Series C
- Echo Health Ventures (https://capitalatlas.ai/funds/echo-health-ventures) — Series C
- Mosaic Health Solutions (https://capitalatlas.ai/funds/mosaic-health-solutions) — Series C